MedTrace Logo

A Comparison of Esmolol and Remifentanil to Reduce Blood Loss

NCT01752959 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-12-19

No results posted yet for this study

Summary

In this prospective randomized study we aimed to compare the effects of esmolol and remifentanil on intraoperative bleeding surgical field conditions in nasal surgery

Conditions

  • Deviation Septum Nasal

Interventions

DRUG

Remifentanil

0.1-0.3 micg/kg/min Remifentanil iv infusion

DRUG

Esmolol

500 μcg/kg/dk esmolol iv lading dose after 50-500 μcg/kg/dk esmolol iv infusion

Sponsors & Collaborators

  • Diskapi Teaching and Research Hospital

    lead OTHER

Principal Investigators

  • Ruveyda D Acıkgoz, Trainee · Ankara Diskapi Yildirim Beyazit Teaching and Research Hospital, Turkey.

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01752959 on ClinicalTrials.gov